[English] 日本語
Yorodumi- PDB-6vgg: Crystal structure of the DNA binding domains of human transcripti... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 6vgg | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Crystal structure of the DNA binding domains of human transcription factor ERG, human Runx2 bound to core binding factor beta (Cbfb), and mithramycin, in complex with 16mer DNA CAGAGGATGTGGCTTC | |||||||||
Components |
| |||||||||
Keywords | TRANSCRIPTION / Ewing sarcoma / enhancer / transcription factor / oncogenesis / prostate cancer / ETS-family / Runt-family | |||||||||
| Function / homology | Function and homology informationligamentous ossification / regulation of fibroblast growth factor receptor signaling pathway / RUNX3 regulates RUNX1-mediated transcription / osteoblast fate commitment / RUNX1 regulates transcription of genes involved in BCR signaling / regulation of odontogenesis of dentin-containing tooth / chondrocyte development / RUNX1 regulates transcription of genes involved in interleukin signaling / RUNX2 regulates bone development / core-binding factor complex ...ligamentous ossification / regulation of fibroblast growth factor receptor signaling pathway / RUNX3 regulates RUNX1-mediated transcription / osteoblast fate commitment / RUNX1 regulates transcription of genes involved in BCR signaling / regulation of odontogenesis of dentin-containing tooth / chondrocyte development / RUNX1 regulates transcription of genes involved in interleukin signaling / RUNX2 regulates bone development / core-binding factor complex / RUNX1 regulates expression of components of tight junctions / positive regulation of CD8-positive, alpha-beta T cell differentiation / RUNX2 regulates chondrocyte maturation / negative regulation of CD4-positive, alpha-beta T cell differentiation / bHLH transcription factor binding / positive regulation of chondrocyte differentiation / lymphocyte differentiation / RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) / response to sodium phosphate / RUNX2 regulates genes involved in cell migration / YAP1- and WWTR1 (TAZ)-stimulated gene expression / Transcriptional regulation by RUNX2 / RUNX2 regulates genes involved in differentiation of myeloid cells / RUNX1 regulates transcription of genes involved in differentiation of keratinocytes / endochondral ossification / SMAD protein signal transduction / embryonic cranial skeleton morphogenesis / myeloid cell differentiation / RUNX3 Regulates Immune Response and Cell Migration / definitive hemopoiesis / embryonic forelimb morphogenesis / Regulation of RUNX1 Expression and Activity / RUNX1 regulates transcription of genes involved in differentiation of myeloid cells / osteoblast development / RUNX1 regulates transcription of genes involved in WNT signaling / RUNX1 regulates estrogen receptor mediated transcription / smoothened signaling pathway / positive regulation of stem cell proliferation / bone mineralization / RUNX2 regulates osteoblast differentiation / RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known / odontogenesis of dentin-containing tooth / regulation of cell differentiation / hemopoiesis / RUNX3 regulates p14-ARF / T cell differentiation / regulation of ossification / chondrocyte differentiation / positive regulation of osteoblast differentiation / BMP signaling pathway / cell maturation / ossification / epithelial cell proliferation / positive regulation of epithelial cell proliferation / stem cell proliferation / negative regulation of smoothened signaling pathway / stem cell differentiation / Regulation of RUNX3 expression and activity / RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function / chromatin DNA binding / Transcriptional regulation of granulopoiesis / neuron differentiation / protein polyubiquitination / Regulation of RUNX2 expression and activity / sequence-specific double-stranded DNA binding / osteoblast differentiation / RUNX1 regulates transcription of genes involved in differentiation of HSCs / DNA-binding transcription activator activity, RNA polymerase II-specific / transcription regulator complex / gene expression / Estrogen-dependent gene expression / sequence-specific DNA binding / transcription by RNA polymerase II / DNA-binding transcription factor activity, RNA polymerase II-specific / cell differentiation / transcription coactivator activity / protein phosphorylation / RNA polymerase II cis-regulatory region sequence-specific DNA binding / DNA-binding transcription factor activity / ribonucleoprotein complex / protein domain specific binding / negative regulation of DNA-templated transcription / chromatin binding / positive regulation of gene expression / regulation of transcription by RNA polymerase II / chromatin / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / signal transduction / positive regulation of transcription by RNA polymerase II / DNA binding / nucleoplasm / ATP binding / nucleus / membrane / cytoplasm / cytosol Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 4.31 Å | |||||||||
Authors | Hou, C. / Rohr, J. / Tsodikov, O.V. | |||||||||
| Funding support | United States, 2items
| |||||||||
Citation | Journal: Structure / Year: 2021Title: Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. Authors: Hou, C. / Mandal, A. / Rohr, J. / Tsodikov, O.V. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 6vgg.cif.gz | 204.8 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb6vgg.ent.gz | 158.6 KB | Display | PDB format |
| PDBx/mmJSON format | 6vgg.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 6vgg_validation.pdf.gz | 406.8 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 6vgg_full_validation.pdf.gz | 409 KB | Display | |
| Data in XML | 6vgg_validation.xml.gz | 2.1 KB | Display | |
| Data in CIF | 6vgg_validation.cif.gz | 6 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/vg/6vgg ftp://data.pdbj.org/pub/pdb/validation_reports/vg/6vgg | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 6vg2C ![]() 6vg8C ![]() 6vgdC ![]() 6vgeSC S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
-Protein , 3 types, 3 molecules ADG
| #1: Protein | Mass: 14927.827 Da / Num. of mol.: 1 / Fragment: DNA binding domain Source method: isolated from a genetically manipulated source Details: The N-terminal GPHM sequence is left over from the affinity tag after its cleavage. Source: (gene. exp.) Homo sapiens (human) / Gene: ERG / Production host: ![]() |
|---|---|
| #4: Protein | Mass: 19542.148 Da / Num. of mol.: 1 / Fragment: DNA binding domain Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: RUNX2, AML3, CBFA1, OSF2, PEBP2A / Production host: ![]() |
| #5: Protein | Mass: 18263.381 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: The N-terminal sequence AGSSHHHHHHSQDP is the affinity tag. Source: (gene. exp.) Homo sapiens (human) / Gene: CBFB / Production host: ![]() |
-DNA chain , 2 types, 2 molecules BC
| #2: DNA chain | Mass: 4954.214 Da / Num. of mol.: 1 / Source method: obtained synthetically / Details: Synthetic DNA / Source: (synth.) Homo sapiens (human) |
|---|---|
| #3: DNA chain | Mass: 4843.156 Da / Num. of mol.: 1 / Source method: obtained synthetically / Details: Synthetic DNA / Source: (synth.) Homo sapiens (human) |
-Non-polymers , 3 types, 5 molecules 




| #6: Chemical | | #7: Chemical | ChemComp-MG / | #8: Water | ChemComp-HOH / | |
|---|
-Details
| Has ligand of interest | Y |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 4.09 Å3/Da / Density % sol: 69.9 % |
|---|---|
| Crystal grow | Temperature: 294 K / Method: vapor diffusion, hanging drop Details: 0.3 M K/Na Tartrate, 50 mM Hepes, pH 7.0, soaked in 1 mM mithramycin-Mg |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 22-ID / Wavelength: 1 Å |
| Detector | Type: DECTRIS EIGER2 X 16M / Detector: PIXEL / Date: Feb 13, 2018 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
| Reflection | Resolution: 4.3→50 Å / Num. obs: 7632 / % possible obs: 98.3 % / Redundancy: 15.7 % / Rmerge(I) obs: 0.086 / Net I/σ(I): 28.6 |
| Reflection shell | Resolution: 4.3→4.37 Å / Rmerge(I) obs: 0.871 / Num. unique obs: 348 / CC1/2: 0.934 / % possible all: 93.5 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 6VGE Resolution: 4.31→35 Å / Cor.coef. Fo:Fc: 0.953 / Cor.coef. Fo:Fc free: 0.925 / SU B: 163.205 / SU ML: 0.938 / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R Free: 0.875 Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : WITH TLS ADDED
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 471.04 Å2 / Biso mean: 287.314 Å2 / Biso min: 175.73 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 4.31→35 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Resolution: 4.31→4.415 Å / Rfactor Rfree error: 0
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
United States, 2items
Citation













PDBj


















































